Evidence map›Paper›PMID 38873084›Full record

ArticleChemical science2024

Visible light-driven dearomative ring expansion of (aza)arenes to access dihydrofuran-based polycyclic compounds.

Linghong Zhang, Mengdi You, Xu Ban, Xiaowei Zhao, Yanli Yin, Shanshan Cao, Zhiyong Jiang

Abstract read
In one paragraph

Article in Chemical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Linghong ZhangKey Laboratory of Natural Medicine and Immuno-Engineering of Henan Province, Henan University Kaifeng Henan P. R. China 475004 chmjzy@henu.edu.cn.
Mengdi YouSchool of Chemistry and Chemical Engineering, Pingyuan Laboratory, Henan Normal University Xinxiang Henan P. R. China 453007 caoshanshan@htu.edu.cn.
Xu BanSchool of Chemistry and Chemical Engineering, Pingyuan Laboratory, Henan Normal University Xinxiang Henan P. R. China 453007 caoshanshan@htu.edu.cn.
Xiaowei ZhaoKey Laboratory of Natural Medicine and Immuno-Engineering of Henan Province, Henan University Kaifeng Henan P. R. China 475004 chmjzy@henu.edu.cn.
Yanli YinSchool of Chemistry and Chemical Engineering, Pingyuan Laboratory, Henan Normal University Xinxiang Henan P. R. China 453007 caoshanshan@htu.edu.cn.
Shanshan CaoSchool of Chemistry and Chemical Engineering, Pingyuan Laboratory, Henan Normal University Xinxiang Henan P. R. China 453007 caoshanshan@htu.edu.cn.
Zhiyong JiangKey Laboratory of Natural Medicine and Immuno-Engineering of Henan Province, Henan University Kaifeng Henan P. R. China 475004 chmjzy@henu.edu.cn.ORCID https://orcid.org/0000-0002-6350-7429

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The dearomative expansion of aromatic rings has long been pursued by chemists due to its potential to provide tractable approaches for synthesizing valuable non-aromatic molecules. To circumvent the conventional use of hazardous and unstable diazo compounds, photochemical synthesis has recently emerged as a promising platform. However, protocols that can effectively handle both arenes and azaarenes remain scarce. Herein, we introduce a generic strategy that efficiently converts β-(aza)aryl-β-substituted enones into biologically significant cycloheptatriene derivatives, including their aza-variants. This method allows for the easy modulation of diverse functional groups on the product and demonstrates a wide substrate scope, evidenced by its excellent tolerance to various drug motifs and good compatibility with five-membered azaarenes undergoing ring expansion. Moreover, DFT calculations of plausible mechanisms have motivated the implementation of an important cascade diradical recombination strategy for 1,3-dienones, thus facilitating the synthesis of valuable 2-oxabicyclo[3.1.0]hex-3-ene derivatives.

Identifiers

PMID38873084
PMCPMC11168080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.